[1]
“The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review”, Reumatismo, Jul. 2025, doi: 10.4081/reumatismo.2025.1835.